Document Detail

The benefit of oestrogens and progestogens in postnatal depression.
MedLine Citation:
PMID:  12881067     Owner:  NLM     Status:  MEDLINE    
Postnatal depression, with a prevalence of at least 10%, is a common complication of the puerperium. The aetiology is unclear, specific diagnostic criteria cannot be drawn and the treatment options are limited. As hormones are thought to contribute to its pathophysiology, the supplementation with either progesterone or oestrogen might be of prophylactic and/or therapeutic value in postnatal depression. Research into hormonal prophylaxis and treatment of postnatal depression (PND) is limited. This review article is aimed at exploring the evidence available regarding the use of oestrogen and progesterone in postnatal depression. A search of electronic databases Medline, Psychinfo, Embase and published books from 1970 to 2002 was carried out. The search strategy was limited to the English language. Of 193 articles, 30 were chosen and all 30 copies were identified and analysed critically. Prophylactic and treatment value were separately analysed for both oestrogen and progesterone. Some uncontrolled studies by Dalton (1982, 1985) report the benefit of progesterone in preventing postnatal depression. The value of oestrogen in preventing and treating this disorder is suggested by some articles but the methodological shortcomings in these studies make the study results unreliable. In addition, the use of oestrogen in the postnatal period may have significant side effects. Use of synthetic progesterone is associated with depression in the postnatal period and should be used with caution. Oestrogen therapy may be of modest value in severe postnatal depression.
J Karuppaswamy; R Vlies
Related Documents :
24345307 - Observer-rated depression in long-term care: frequency and risk factors.
20169377 - An association study between the val66met polymorphism of the bdnf gene and postpartum ...
24157077 - Effect of aerobic exercise on cognition, academic achievement, and psychosocial functio...
24014137 - The value of impulsivity to define subgroups of addicted individuals differing in perso...
19349417 - Differences in cephalometric measurements: a comparison of digital versus hand-tracing ...
17136947 - Development of a quantifiable symptom assessment tool for patients with chronic bronchi...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology     Volume:  23     ISSN:  0144-3615     ISO Abbreviation:  J Obstet Gynaecol     Publication Date:  2003 Jul 
Date Detail:
Created Date:  2003-07-25     Completed Date:  2003-10-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8309140     Medline TA:  J Obstet Gynaecol     Country:  England    
Other Details:
Languages:  eng     Pagination:  341-6     Citation Subset:  IM    
Wrexham Maelor Hospital, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antidepressive Agents / therapeutic use
Clinical Trials as Topic
Depression, Postpartum / drug therapy*,  etiology,  prevention & control
Estrogens / therapeutic use*
Progesterone / therapeutic use*
Progesterone Congeners / adverse effects
Reg. No./Substance:
0/Antidepressive Agents; 0/Estrogens; 0/Progesterone Congeners; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Computer-assisted instruction: guiding learning through a key features approach in a community-based...
Next Document:  Ultracision in gynaecological laparoscopic surgery.